Cost-effectiveness indicator for colorectal cancer therapy-Reference-Cited by-同舟云学术

Cost-effectiveness indicator for colorectal cancer therapy

Published:2020-12-28 Issue:4 Volume: Page:24-28
ISSN:1609-1175
Container-title:Pacific Medical Journal
language:
Short-container-title:Tihookeanskij medicinskij žurnal

Author:

Eliseeva E. V.¹,Petukhova Yu. Yu.²^ORCID,Petukhova A. G.¹

Affiliation:

1. Pacific State Medical University

2. Pacific State Medical University; Primorskiy Regional Oncological Dispensary

Abstract

Contemporary data on different therapy schemes for colorectal cancer are presented from the point of view of “costeffectiveness” indicator. There is an information about Federal programs aimed at increasing annual healthcare financing connected with preventing and curing malignancies. The statistics of the annual growth in colon and rectum cancer rates is discussed. An actual problem of increasing number of resource-intensive medicines for oncology treatment is stated. This is the reason to analyze cost-effectiveness.

Publisher

Pacific State Medical University

Subject

General Medicine

Reference30 articles.

1. Idiyatullina ET, Pavlov VN. Modern aspects of epidemiology, diagnosis and therapy of colorectal cancer. Medical Bulletin of Bashkortostan. 2017;4:115–21 (In Russ).

2. Klinicheskie recomendacii. Zlokachestvenie novoobrazovinia obodochnoi kishki i rectosigmoidnogo otdela. Moscow: Ministry of Health of the Russian Federation; 2020:57 (In Russ).

3. Fedorov VE, Podelyakin KA. Epidemiological aspects of colorectal cancer (review). Medical Almanac. 2017;4:145–8 (In Russ).

4. Prudnikova YaI, Kruchinina MV, Svetlova IO, Kurilovich SA, Voitsitsky VE, Ryaguzov ME, Khadagaev IB. Colorectal cancer: Risk factors and protection. Experimental and Clinical Gastroenterology. 2017;9:96–105 (In Russ).

5. Shtygasheva OV, Ageeva ES, Guzar YaR. Anamnestic predictors of colorectal cancer. Experimental and Clinical Gastroenterology. 2019;2:50–4 (In Russ).